Biocept (BIOC) Reports Q1 Loss of $0.61

Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.61), versus ($3.33) reported last year. Revenue for the quarter came in at $976 thousand versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Cloudflare Inc. (NET) PT Raised to $330 at Citizens on Infrastructure Subsector Strength
• Kepler Cheuvreux Upgrades Sandvik AB (SAND:SS) (SDVKY) to Buy
• CLSA Starts salesforce.com (CRM) at Hold (3)